Human SP-A 3′-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 5 28-5, 2003, Pages

  Wang, Guirong ^a   Guo, Xiaoxuan ^a   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

3 untranslated region; Allele; Gene regulation; Surfactant protein A

Indexed keywords

DEXAMETHASONE; MESSENGER RNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA VECTOR; DRUG EFFECT; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; REPORTER GENE;

EID: 0037404344     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00375.2002     Document Type: Article

References (63)

1. Almawi WY, Abou Jaoude MM, and Li XC. Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects. Hematol Oncol 20: 17-32, 2002.
2. Almawi WY and Melemedjian OK. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71: 9-15, 2002.
3. Almawi WY and Melemedjian OK. Negative regulation of nuclear factor-κB activation and function by glucocorticoids. J Mol Endocrinol 28: 69-78, 2002.
4. Baker DM, Wang SL, Bell DJ, Drevon CA, and Davis RA. One or more labile proteins regulate the stability of chimeric mRNAs containing the 3′-untranslated region of cholesterol-7α-hydroxylase mRNA. J Biol Chem 275: 19985-19991, 2000.
5. Ballard PL, Hawgood S, Liley H, Wellenstein G, Gonzales LW, Benson B, Cordell B, and White RT. Regulation of pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung. Proc Natl Acad Sci USA 83: 9527-9531, 1986.
6. Bhuta T and Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 79: F26-F33, 1998.
7. Binder R, Hwang SP, Ratnasabapathy R, and Williams DL. Degradation of apolipoprotein II mRNA occurs via endonucleolytic cleavage at 5′-AAU-3′/5′-UAA-3′ elements in single-stranded loop domains of the 3′-noncoding region. J Biol Chem 264: 16910-16918, 1989.
8. Boggaram V, Smith ME, and Mendelson CR. Posttranscriptional regulation of surfactant protein A messenger RNA in human fetal lung in vitro by glucocorticoids. Mol Endocrinol 5: 414-423, 1991.
9. Chen CY, Xu N, and Shyu AB. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 15: 5777-5788, 1995.
10. Conne B, Stutz A, and Vassalli JD. The 3′-untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 6: 637-641, 2000.
11. Craig AW, Haghighat A, Yu AT, and Sonenberg N. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature 392: 520-523, 1998.
12. Cummings JJ, D'Eugenio DB, and Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505-1510, 1989.
13. Day DA and Tuite MF. Posttranscriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 157: 361-371, 1998.
14. Dekowski SA and Snyder JM. The combined effects of insulin and cortisol on surfactant protein mRNA levels. Pediatr Res 38: 513-521, 1995.
15. Dekowski SA and Snyder JM. Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro. Endocrinology 131: 669-676, 1992.
16. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, Centra M, Spampinato D, Santagati MG, Ercolino T, Cisternino C, Soccio T, Mastroianno S, Tassi V, Almgren P, Pizzuti A, Vigneri R, and Trischitta V. A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70: 806-812, 2002.
17. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, and Floros J. Novel, non-radioactive, simple, and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 15: 269-281, 1999.
18. Dulkerian SJ, Gonzales LW, Ning Y, and Ballard PL. Regulation of surfactant protein D in human fetal lung. Am J Respir Cell Mol Biol 15: 781-786, 1996.
19. Floros J and Phelps DS. Pulmonary surfactant. In: Anesthesia: Biologic Foundations, edited by Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuck J, and Saidman LJ. Philadelphia, PA: Lippincott-Raven, 1997, p. 1259-1279.
20. Garcia-Gras EA, Chi P, and Thompson EA. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3′-untranslated region of the mRNA. J Biol Chem 275: 22001-22008, 2000.
21. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, and Kulozik AE. Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 28: 389-392, 2001.
22. Gingras AC, Raught B, and Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68: 913-963, 1999.
23. Gray NK, Coller JM, Dickson KS, and Wickens M. Multiple portions of poly(A)-binding protein stimulate translation in vivo. EMBO J 19: 4723-4733, 2000.
24. Gray NK and Wickens M. Control of translation initiation in animals. Annu Rev Cell Dev Biol 14: 399-458, 1998.
25. Hoover RR and Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 18: 353-362, 1998.
26. Hoover RR and Floros J. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol Lung Cell Mol Physiol 276: L917-L924, 1999.
27. Hoover RR, Thomas KH, and Floros J. Glucocorticoid inhibition of human SP-A1 promoter activity in NCI-H441 cells. Biochem J 340: 69-76, 1999.
28. Iannuzzi DM, Ertsey R, and Ballard PL. Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process. Am J Physiol Lung Cell Mol Physiol 264: L236-L244, 1993.
29. Jacobs KA, Phelps DS, Steinbrink R, Fisch J, Kriz R, Mitsock L, Dougherty JP, Taeusch HW, and Floros J. Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem 262: 9808-9811, 1987.
30. Jones R, Wincott E, Elbourne D, and Grant A. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics 96: 897-906, 1995.
31. Karinch AM, Deiter G, Ballard PL, and Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim Biophys Acta 1398: 192-202, 1998.
32. Katyal SL, Singh G, and Locker J. Characterization of a second human pulmonary surfactant-associated protein SP-A gene. Am J Respir Cell Mol Biol 6: 446-452, 1992.
33. Kazzi NJ, Brans YW, and Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 86: 722-727, 1990.
34. Krizkova L, Sakthivel R, Olowe SA, Rogan PK, and Floros J. Human SP-A: genotype and single-strand conformation polymorphism analysis. Am J Physiol Lung Cell Mol Physiol 266: L519-L527, 1994.
35. Kumar AR and Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol Lung Cell Mol Physiol 274: L177-L185, 1998.
36. Lagnado CA, Brown CY, and Goodall GJ. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol Cell Biol 14: 7984-7995, 1994.
37. Lee NH, Earle-Hughes J, and Fraser CM. Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA. Elements involved in mRNA stability are localized in the 3'-untranslated region. J Biol Chem 269: 4291-4298, 1994.
38. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, and Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 158: 4336-4340, 1997.
39. Liley HG, White RT, Benson BJ, and Ballard PL. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung. Proc Natl Acad Sci USA 85: 9096-9100, 1988.
40. Liu C, Morrisey EE, and Whitsett JA. GATA-6 is required for maturation of the lung in late gestation. Am J Physiol Lung Cell Mol Physiol 283: L468-L475, 2002.
41. Massaro GD and Massaro D. Formation of alveoli in rats: postnatal effect of prenatal dexamethasone. Am J Physiol Lung Cell Mol Physiol 263: L37-L41, 1992.
42. McCormick SM and Mendelson CR. Human SP-A1 and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids. Am J Physiol Lung Cell Mol Physiol 266: L367-L374, 1994.
43. Mendelson CR. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu Rev Physiol 62: 875-915, 2000.
44. Moriette G, Mikaeloff Y, Jarreau PH, and Desfrere L. Corticosteroids and chronic lung disease in extremely immature infants: a dilemma. Pediatr Pulmonol Suppl 18: 209-211, 1999.
45. Moseley PL, Wallen ES, McCafferty JD, Flanagan S, and Kern JA. Heat stress regulates the human 70-kDa heat-shock gene through the 3′-untranslated region. Am J Physiol Lung Cell Mol Physiol 264: L533-L537, 1993.
46. Mullner EW and Kuhn LC. A stem-loop in the 3′-untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53: 815-825, 1988.
47. 2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273: 32312-32321, 1998.
48. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 68: 330-336, 1993.
49. Okajima S, Matsuda T, Cho K, Matsumoto Y, Kobayashi Y, and Fujimoto S. Antenatal dexamethasone administration impairs normal postnatal lung growth in rats. Pediatr Res 49: 777-781, 2001.
50. O'Reilly MA, Gazdar AF, Morris RE, and Whitsett JA. Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta 970: 194-204, 1988.
51. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol 20: 269-292, 2001.
52. Planer BC, Ning Y, Kumar SA, and Ballard PL. Transcriptional regulation of surfactant proteins SP-A and SP-B by phorbol ester. Biochim Biophys Acta 1353: 171-179, 1997.
53. Rishi A, Hatzis D, McAlmon K, and Floros J. An allelic variant of the 6A gene for human surfactant protein A. Am J Physiol Lung Cell Mol Physiol 262: L566-L573, 1992.
54. Sambrook J, Fritsch EF, and Maniatis T. Enzymes used in molecular cloning. In: Molecular cloning: a laboratory manual (2nd ed.), edited by Nolan C. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989, p. 5.1-5.95.
55. Scavo LM, Ertsey R, and Gao BQ. Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors. Am J Physiol Lung Cell Mol Physiol 275: L653-L669, 1998.
56. Shah OJ, Iniguez-Lluhi JA, Romanelli A, Kimball SR, and Jefferson LS. The activated glucocorticoid receptor modulates presumptive autoregulation of ribosomal protein S6 protein kinase, p70 S6K. J Biol Chem 277: 2525-2533, 2002.
57. Snyder JM and Mendelson CR. Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro. Endocrinology 120: 1250-1257, 1987.
58. Wang G, Phelps DS, Umstead TM, and Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-α production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 278: L946-L954, 2000.
59. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, and Floros J. The effect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production. Environ Health Perspect 110: 79-84, 2002.
60. White RT, Damm D, Miller J, Spratt K, Schilling J, Hawgood S, Benson B, and Cordell B. Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature 317: 361-363, 1985.
61. Xu N, Chen CY, and Shyu AB. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol 17: 4611-4621, 1997.
62. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, and Lien YJ. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101: E7, 1998.
63. Zubiaga AM, Belasco JG, and Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15: 2219-2230, 1995.